Hasten Biopharmaceuticals’ Acquisition of 14 Product Portfolios from Celltrion Healthcare

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition. Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Plenty’s $680m JV with Mawarid

Freshfields advised Plenty on its Joint Venture with Mawarid. Plenty Unlimited Inc. (“Plenty”) and Mawarid Holding Investment (“Mawarid”)—a subsidiary of Alpha Dhabi Holding, a major publicly...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

itrinity’s Acquisition JAM Start

Fox Williams has advised the majority shareholders of JAM Start, Andy McNulty and Joseph Jones, on the sale. itrinity s.r.o. has acquired JAM Start, a company...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here